CA1055945A - Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms - Google Patents

Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms

Info

Publication number
CA1055945A
CA1055945A CA238,781A CA238781A CA1055945A CA 1055945 A CA1055945 A CA 1055945A CA 238781 A CA238781 A CA 238781A CA 1055945 A CA1055945 A CA 1055945A
Authority
CA
Canada
Prior art keywords
chloro
hydrogen
methyl
formula
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA238,781A
Other languages
English (en)
French (fr)
Inventor
Charles L. Zirkle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Inc
Original Assignee
Smith Kline and French Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Canada Ltd filed Critical Smith Kline and French Canada Ltd
Application granted granted Critical
Publication of CA1055945A publication Critical patent/CA1055945A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA238,781A 1974-11-06 1975-10-31 Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms Expired CA1055945A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (1)

Publication Number Publication Date
CA1055945A true CA1055945A (en) 1979-06-05

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA238,781A Expired CA1055945A (en) 1974-11-06 1975-10-31 Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms

Country Status (17)

Country Link
JP (1) JPS5826754B2 (ja)
AU (1) AU498298B2 (ja)
BE (1) BE835224A (ja)
CA (1) CA1055945A (ja)
CH (1) CH624403A5 (ja)
DE (1) DE2549841A1 (ja)
DK (1) DK139429B (ja)
ES (1) ES442357A1 (ja)
FR (1) FR2290202A1 (ja)
HU (1) HU174639B (ja)
IE (1) IE42137B1 (ja)
IL (1) IL48400A (ja)
LU (1) LU73714A1 (ja)
NL (1) NL7512974A (ja)
NZ (1) NZ179139A (ja)
PH (1) PH12158A (ja)
ZA (1) ZA756550B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (fr) * 1976-07-09 1978-02-03 Merck & Co Inc 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
EP1306376A1 (en) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
US7060711B2 (en) 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1644373A1 (en) * 2003-06-27 2006-04-12 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
WO2007030089A1 (en) 2004-08-05 2007-03-15 Janssen Pharmaceutica N.V. Tricyclic delta- opioid modulators
CN101119992A (zh) 2004-12-22 2008-02-06 詹森药业有限公司 三环δ阿片样物质调节剂
US7439239B2 (en) 2004-12-22 2008-10-21 Janssen Pharmaceutica N.V. Tricyclic δ- opioid modulators
EP1836196A1 (en) * 2004-12-22 2007-09-26 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
JP2008526878A (ja) 2005-01-06 2008-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式δ−オピオイド調節剤
CA2612491A1 (en) 2005-06-16 2006-12-28 Janssen Pharmaceutica N.V. Tricyclic opioid modulators
JP5044562B2 (ja) 2006-09-29 2012-10-10 日本臓器製薬株式会社 オキセピン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (ja) * 1960-02-25
NL122808C (ja) * 1961-09-29
DE1670118A1 (de) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (ja) * 1973-05-17 1975-02-26

Also Published As

Publication number Publication date
NZ179139A (en) 1978-04-28
HU174639B (hu) 1980-02-28
BE835224A (fr) 1976-05-04
LU73714A1 (ja) 1976-06-11
DK495775A (ja) 1976-05-07
IL48400A (en) 1979-01-31
PH12158A (en) 1978-11-10
DE2549841C2 (ja) 1988-07-07
NL7512974A (nl) 1976-05-10
DK139429C (ja) 1979-08-06
JPS5170768A (ja) 1976-06-18
ES442357A1 (es) 1977-04-01
FR2290202B1 (ja) 1980-05-23
CH624403A5 (en) 1981-07-31
DE2549841A1 (de) 1976-05-13
JPS5826754B2 (ja) 1983-06-04
ZA756550B (en) 1976-09-29
IE42137B1 (en) 1980-06-04
AU498298B2 (en) 1979-03-01
FR2290202A1 (fr) 1976-06-04
AU8624775A (en) 1977-05-05
IE42137L (en) 1976-05-06
IL48400A0 (en) 1976-01-30
DK139429B (da) 1979-02-19

Similar Documents

Publication Publication Date Title
CA1055945A (en) Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4086350A (en) Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
US3014911A (en) Derivatives of dibenzo[a, e]cycloheptatriene
US5294619A (en) Arylpiperidine derivatives
IE44055B1 (en) Phthalanes
US2684965A (en) Aminoalkylpiperidines
US3470188A (en) 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
US4929621A (en) 1-1[(2-pyrimidinyl)amino-alkyl]piperidines, their preparation and their application in therapy
NO147029B (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme trisubstituerte 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepinforbindelser
US4013668A (en) 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds
US2976291A (en) Ethers of z
CA1102807A (en) Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins
JPS6036436B2 (ja) １０‐〔ω‐（ベンゾイルピペリジニル）アルキル〕フエノチアジアジンおよびその酸付加塩ならびにそれらの製造法
Kaiser et al. Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans
US4042695A (en) Thiaxanthene derivatives, compositions thereof and methods of treating therewith
IE67871B1 (en) Novel benzothiopyranylamines
US2941999A (en) Phenthiazine derivatives
US4032640A (en) 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes
US3316272A (en) Heterocyclic derivatives of triphenyl-ethylenes, triphenylethanes and triphenylethanols
CA1090334A (en) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro- 1h-3-benzazepines having dopaminergic activity
US3140284A (en) New phenothiazine derivatives and a process for the production thereof
NO138806B (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater
US3094526A (en) 10-[(3-and 4-hydroxy-1-piperidyl) loweralkyl phenothiazines
EP0364091B1 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides
US3743735A (en) Pharmaceutical compositions containing tropanol esters of alpha-phenyl-alpha-cyclopentyl-acetic acid and methods of use